89 related articles for article (PubMed ID: 9417520)
21. "Room temperature" use of CHROMagar Candida.
Odds FC; Davidson A
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):147-50. PubMed ID: 11109012
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of the new colorimetric VITEK 2 yeast identification card versus the older fluorometric card and of CHROMagar Candida as a source medium with the new card.
Aubertine CL; Rivera M; Rohan SM; Larone DH
J Clin Microbiol; 2006 Jan; 44(1):227-8. PubMed ID: 16390976
[TBL] [Abstract][Full Text] [Related]
23. PCR-AGE, automated and manual methods to identify Candida strains from veterinary sources: a comparative approach.
Brito EH; Brilhante RS; Cordeiro RA; Sidrim JJ; Fontenelle RO; Melo LM; Albuquerque ES; Rocha MF
Vet Microbiol; 2009 Nov; 139(3-4):318-22. PubMed ID: 19592181
[TBL] [Abstract][Full Text] [Related]
24. Identification of Uncommon
Kim TH; Kweon OJ; Kim HR; Lee MK
J Microbiol Biotechnol; 2016 Dec; 26(12):2206-2213. PubMed ID: 27713213
[TBL] [Abstract][Full Text] [Related]
25. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
J Clin Microbiol; 2007 Mar; 45(3):796-802. PubMed ID: 17215344
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures.
Yaman G; Akyar I; Can S
Diagn Microbiol Infect Dis; 2012 May; 73(1):65-7. PubMed ID: 22578939
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Vitek-MS™ system in the identification of Candida isolates from bloodstream infections.
Ruiz de Alegría Puig C; Agüero-Balbín J; Fernández-Mazarrasa C; Martínez-Martínez L
Rev Iberoam Micol; 2018; 35(3):130-133. PubMed ID: 30343836
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species.
Guzel AB; Ilkit M; Akar T; Burgut R; Demir SC
Med Mycol; 2011 Jan; 49(1):16-25. PubMed ID: 20608776
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species.
Fricker-Hidalgo H; Vandapel O; Duchesne MA; Mazoyer MA; Monget D; Lardy B; Lebeau B; Freney J; Ambroise-Thomas P; Grillot R
J Clin Microbiol; 1996 Jul; 34(7):1846-8. PubMed ID: 8784609
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method.
Cejudo MA; Gallego AG; Lacasa EC; Aller AI; Romero A; García JP; Andrés GQ; Martín-Mazuelos E
Med Mycol; 2010 Aug; 48(5):710-9. PubMed ID: 20109092
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens.
Campbell CK; Davey KG; Holmes AD; Szekely A; Warnock DW
J Clin Microbiol; 1999 Mar; 37(3):821-3. PubMed ID: 9986865
[TBL] [Abstract][Full Text] [Related]
32. Identification of medically important
Bayraktar S; Duran N; Duran GG; Eryilmaz N; Aslan H; Önlen C; Özer B
Indian J Med Microbiol; 2017; 35(4):535-542. PubMed ID: 29405146
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of API ID 32C and VITEK-2 to identify Candida dubliniensis.
Cárdenes-Perera CD; Torres-Lana A; Alonso-Vargas R; Moragues-Tosantas MD; Pontón-San Emeterio J; Quindós-Andrés G; Arévalo-Morales MP
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):219-21. PubMed ID: 15541609
[TBL] [Abstract][Full Text] [Related]
34. Comparison of species-level identification and antifungal susceptibility results from diagnostic and reference laboratories for bloodstream Candida surveillance isolates, South Africa, 2009-2010.
Naicker SD; Govender N; Patel J; Zietsman IL; Wadula J; Coovadia Y; Kularatne R; Seetharam S; Govender NP;
Med Mycol; 2016 Nov; 54(8):816-24. PubMed ID: 27335055
[TBL] [Abstract][Full Text] [Related]
35. A comparison of methods for yeast identification including CHROMagar Candida, Vitek system YBC and a traditional biochemical method.
Huang LU; Chen CH; Chou CF; Lu JJ; Chi WM; Lee WH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Oct; 64(10):568-74. PubMed ID: 11791943
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the new API Candida system for identification of the most clinically important yeast species.
Bernal S; Martín Mazuelos E; Chávez M; Coronilla J; Valverde A
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):217-21. PubMed ID: 9884839
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a new extraction protocol for yeast identification by mass spectrometry.
Gouriet F; Ghiab F; Couderc C; Bittar F; Tissot Dupont H; Flaudrops C; Casalta JP; Sambe-Ba B; Fall B; Raoult D; Fenollar F
J Microbiol Methods; 2016 Oct; 129():61-65. PubMed ID: 27498228
[TBL] [Abstract][Full Text] [Related]
38. Candida biotypes isolated from clinical specimens in Malaysia.
Ng KP; Madasamy M; Saw TL; Baki A; He J; Soo-Hoo TS
Mycopathologia; 1998-1999; 144(3):135-40. PubMed ID: 10531679
[TBL] [Abstract][Full Text] [Related]
39. Comparative evaluation of a commercial system for identification of Candida lusitaniae.
Michel-Nguyen A; Favel A; Chastin C; Selva M; Regli P
Eur J Clin Microbiol Infect Dis; 2000 May; 19(5):393-5. PubMed ID: 10898145
[TBL] [Abstract][Full Text] [Related]
40. Yeast identification in routine clinical microbiology laboratory and its clinical relevance.
Agarwal S; Manchanda V; Verma N; Bhalla P
Indian J Med Microbiol; 2011; 29(2):172-7. PubMed ID: 21654115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
